The infantile cerebral palsy (ICP) is known as one of the most common disease of the nervous system in infancy. The use of amino acids compounds for treatment of infantile cerebral palsy (ICP) has well pronounced effects for the following pathology associated with infantile cerebral palsy (ICP):
The amino acids target the impaired brain section that needs help and the amino acid treatment revives those cell systems and structure which have lost their function. Most complex biochemical reactions recover or partly recover and bring the brain structures back to life. Administration of amino acids stimulates neurogenesis, activation of dormant nerve cells and a pouch child’s central nervous system ability to recover completely or partially.
This explains that amino acid treatment has a permanent effect and additional improvements are usually observed after the completion of the treatment. The best results of therapy with amino acid compounds are achieved in individuals with a spastic form of infantile cerebral palsy (ICP) and an improved psycho neurological condition can be observed in all cases. The first signs of improvement, reduced spasticity, can be observed within several days of treatment. Normalization of the motor function is achieved after several months of treatment, depending on the individual development of the person with infantile cerebral palsy (ICP).
Treatment of athetoid or dyskinetic (uncontrolled and involuntary movements) and hypotonia seems to be more difficult. Amino acid compounds are administered on a long-term basis and the effectiveness is individual, but even in complicated cases there are well pronounced improvements in all symptoms related to infantile cerebral palsy (ICP), including new quality of movement (larger extent and precision of movements). The children became capable of moving from side to side on their own, sitting by themselves, standing and have improved gait.
Eye pathology is a frequently found problem in patients with infantile cerebral palsy (ICP). When administering amino acids, an improvement of sight can be observed after two to three months. In patients with amaurosis caused by the atrophy of the optical nerve, an improvement occurs in all cases. After several months of administration, an improvement of nystagmus and ptosis occurs, the amplitude and range of motion of the eyeball increases and the angle decreases by 5-20 degrees in cases of strabismus. These effects lead to the possibility of fixation of sight and binocular vision.
Infantile cerebral palsy (ICP) is a group of chronic disorders impairing control of movement related to a brain injury. Symptoms vary in severity, but generally range from involuntary muscle movements to excessive muscle tone (spasticity).
Cerebral palsy is classified into several types, such as:
Each form is characterized by specific symptoms for which a specific combination of amino acid should be determined.
In many cases children with infantile cerebral palsy (ICP) have associated medical problems such as: speech and communication problems, mental retardation, behavioral problems, seizures, visual impairment or blindness, hearing loss, food aspiration, gastro esophageal reflux, sleep disorders and many others.
At the moment, conventional medical knowledge holds that infantile cerebral palsy (ICP) cannot be cured and treatment is aimed at improving the child's social adaptation. It suggests long term work of various specialists with a child with cerebral palsy (ICP), these specialists might be:
After many years of experience with amino acid treatment, it has become clear that many of the related specialists have noticed that children who have been treated develop their abilities and skills easier and faster than children who did not have this amino acid treatment.
Infantile cerebral palsy (ICP) Elisa
Maritim HotelGoethestraße 7, 80336 München
Best Western Plus Hotel UniversoVia P. Amedeo 5/b
Hotel Wilga Krakówul. Przedwiośnie 16 30-502 Kraków www.hotelwilgakrakow.pl